256 related articles for article (PubMed ID: 33102202)
21. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Gao L; Zhao A; Wang X
Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
[TBL] [Abstract][Full Text] [Related]
22. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
23. YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Su G; Liu T; Han X; Sun H; Che W; Hu K; Xiao J; Li Y; Liu Y; Li W; Mei H
Front Pharmacol; 2021; 12():709548. PubMed ID: 34512342
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
Zhang F; Liu L; Wu P; Li S; Wei D
Transl Androl Urol; 2021 Feb; 10(2):785-796. PubMed ID: 33718080
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
26. PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis.
Luo Y; Chen L; Wang G; Qian G; Liu X; Xiao Y; Wang X; Qian K
J Cancer; 2019; 10(10):2319-2331. PubMed ID: 31258735
[TBL] [Abstract][Full Text] [Related]
27. Molecular Characterization of m6A Modifications in Non-Clear Cell Renal Cell Carcinoma and Potential Relationship with Pathological Types.
Xiang X; Guo Y; Chen Z; Mo Z
Int J Gen Med; 2022; 15():1595-1608. PubMed ID: 35210831
[TBL] [Abstract][Full Text] [Related]
28. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
Front Oncol; 2020; 10():769. PubMed ID: 32582536
[No Abstract] [Full Text] [Related]
29. Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma.
Liu L; Ding G
Exp Ther Med; 2014 Oct; 8(4):1055-1058. PubMed ID: 25187796
[TBL] [Abstract][Full Text] [Related]
30. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
Front Oncol; 2020; 10():788. PubMed ID: 32528886
[No Abstract] [Full Text] [Related]
31.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
32. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
[TBL] [Abstract][Full Text] [Related]
33. Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Xu J; Liu Y; Liu J; Shou Y; Xiong Z; Xiong H; Xu T; Wang Q; Liu D; Liang H; Yang H; Yang X; Zhang X
Front Oncol; 2021; 11():659208. PubMed ID: 34249694
[TBL] [Abstract][Full Text] [Related]
34. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
35. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
36. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
Front Oncol; 2020; 10():718. PubMed ID: 32547941
[TBL] [Abstract][Full Text] [Related]
37. High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma.
Zhou J; Zhu Y; Liu Y; Niu P; Chen H; Deng J; Shi D
Transl Androl Urol; 2020 Aug; 9(4):1650-1660. PubMed ID: 32944526
[TBL] [Abstract][Full Text] [Related]
38. High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma.
Wei C; Wu S; Li X; Wang Y; Ren R; Lai Y; Ye J
Oncol Lett; 2013 Feb; 5(2):473-478. PubMed ID: 23420638
[TBL] [Abstract][Full Text] [Related]
39. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
40. Molecular subtypes of m
Guan B; Ren F; Shan W; Zhang S
Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
